Your browser doesn't support javascript.
loading
Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database.
Huang, Guangyi; Liao, Jie; Cai, Songwang; Chen, Zheng; Qin, Xiaoping; Ba, Longhong; Rao, Jingmin; Zhong, Weimin; Lin, Ying; Liang, Yuying; Wei, Liwei; Li, Jinhua; Deng, Kaifeng; Li, Xiangyue; Guo, Zexiong; Wang, Liang; Zhuo, Yumin.
Afiliación
  • Huang G; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Liao J; Department of Oncology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Cai S; Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Chen Z; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Qin X; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Ba L; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Rao J; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Zhong W; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Lin Y; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Liang Y; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Wei L; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Li J; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Deng K; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Li X; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Guo Z; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Wang L; Department of Oncology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Zhuo Y; Department of Urology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Front Oncol ; 12: 949058, 2022.
Article en En | MEDLINE | ID: mdl-36237316
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza